Tuesday, September 16, 2025

Latest

Biotech SPAC Larkspur Health Acquisition Prices US$75 Million IPO

After filing for registration in May 2021, special purpose acquisition company Larkspur Health Acquisition Corp. (Nasdaq: LSPRU) finally started trading publicly on the Nasdaq Global Market yesterday. The company is seeking to raise US$75 million in its initial public offering.

The offering consists of 7.5 million units priced at US$10.00 per unit. Each unit is composed of one common share and three-fourths of a purchase warrant. Each whole warrant is redeemable for one common share at US$11.50 per share.

The company units trade on the Nasdaq big board under the symbol “LSPRU”. Once the securities separate, the company shares and warrants will trade under the ticker symbols “LSPR” and “LSPRW”, respectively.

The proposed offering is being managed by Alliance Global Partners as the sole bookrunner. The company has granted the underwriters a 45-day over-allotment option to purchase additional 1.125 million company units at the same IPO price.

The blank check company will be looking to focus on firms in the biotechnology sector. The SPAC is led by Chairman and CEO Daniel O’Connor, the former CEO of OncoSec Medical–a New Jersey-based biotech firm focused on developing intratumoral cancer immunotherapy.


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

New Found Gold: The Strategic Maritime Resources Purchase

Amex Exploration: Revised Perron PEA Has INSANE Economics

Aris Mining: The Multi Billion Dollar Soto Norte PFS

Recommended

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Goliath Resources Hits 18.58 g/t Gold Over 5.00 Metres At Surebet

Related News

Former Tapestry CEOs-Led Consumer SPAC Acacia Blue Prices US$240 Million IPO

Special purpose acquisition company Bleuacacia (Nasdaq: BLEUU), also referred to as Acacia Blue, started trading...

Thursday, November 18, 2021, 02:17:00 PM

Coinbase Files Listing To Go Public On Nasdaq Amid Bitcoin Boom

The largest US cryptocurrency exchange, Coinbase, has filed with US regulators to go public, as...

Friday, February 26, 2021, 10:46:00 AM

SEMRush: Analyzing Data To Extract Consumer Insights – The Daily Dive

Starting off this week on the Daily Dive is that of Eugene Levin, chief strategy...

Monday, May 10, 2021, 01:30:00 PM

Ex-Blue Origin President-Led SPAC C5 Acquisition Prices US$250 Million IPO

Blank check company C5 Acquisition Corporation (NYSE: CXAC.U) is looking to raise US$250 million for...

Monday, January 10, 2022, 04:46:00 PM

Biopharmaceutical Firm DICE Therapeutics Prices Upsized US$204 Million IPO

Biopharmaceutical company DICE Therapeutics, Inc. (Nasdaq: DICE) started publicly trading on the Nasdaq Global Market...

Thursday, September 16, 2021, 11:08:00 AM